ResMed (ASX:RMD) Result Analyst Comments: Reporting Season, August 2023

Reporting Season: August 2023
07/08/2023 6 min
ResMed (ASX:RMD) Result Analyst Comments: Reporting Season, August 2023

Listen "ResMed (ASX:RMD) Result Analyst Comments: Reporting Season, August 2023"

Descargar episodio Ver en sitio original

Episode Synopsis

Morgans Senior Analyst Dr Derek Jellinek gives an update on ResMed's mixed 4Q, as strong sales across all product lines failed to translate into operating leverage.Check out more from Morgans:Visit the Morgans website: www.morgans.com.auCheck out our blog: www.morgans.com.au/BlogOn Facebook: www.facebook.com/MorgansAUOn Instagram: www.instagram.com/Morgans.AustraliaOn Twitter: twitter.com/MorgansAU

More episodes of the podcast Reporting Season: August 2023

Travel Sector Wrap: Reporting Season, August 2023 21/09/2023
Industrials Sector Wrap: Reporting Season, August 2023 21/09/2023
Technology Sector Wrap: Reporting Season, August 2023 21/09/2023
Retail Sector Wrap: Reporting Season, August 2023 20/09/2023
Mineral Resources (MIN) Result - Analyst Comments | Reporting Season, August 2023 31/08/2023
Lovisa (LOV) Domino's Pizza (DMP) Results - Analyst Comments | Reporting Season, August 2023 29/08/2023
Sonic Healthcare (SHL) & Ramsay Health Care (RHC) Results | Reporting Season, August 2023 25/08/2023
Telstra (TLS) Result - Analyst Comments | Reporting Season, August 2023 21/08/2023
Orora (ORA), Endeavour Group (EDV) & PWR Holdings (PWH) Results | Reporting Season, August 2023 21/08/2023
JB Hi-Fi (JBH) Result - Analyst Comments | Reporting Season, August 2023 16/08/2023
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA